Straumann Holding AG (SAUHF)
USD 116.39
(0.82%)
USD 116.39
(0.82%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 3.39 Billion CHF | 0.65% |
| 2022 | 3.37 Billion CHF | 13.66% |
| 2021 | 2.96 Billion CHF | 16.46% |
| 2020 | 2.54 Billion CHF | 6.64% |
| 2019 | 2.38 Billion CHF | 28.18% |
| 2018 | 1.86 Billion CHF | 11.09% |
| 2017 | 1.67 Billion CHF | 53.99% |
| 2016 | 1.08 Billion CHF | 4.17% |
| 2015 | 1.04 Billion CHF | -9.86% |
| 2014 | 1.16 Billion CHF | 13.83% |
| 2013 | 1.01 Billion CHF | 31.99% |
| 2012 | 772.6 Million CHF | -4.77% |
| 2011 | 811.26 Million CHF | -4.99% |
| 2010 | 853.89 Million CHF | 6.35% |
| 2009 | 802.94 Million CHF | 10.26% |
| 2008 | 728.24 Million CHF | -23.06% |
| 2007 | 946.48 Million CHF | 46.3% |
| 2006 | 646.94 Million CHF | 20.64% |
| 2005 | 536.28 Million CHF | 32.57% |
| 2004 | 404.53 Million CHF | 14.99% |
| 2003 | 351.78 Million CHF | 40.13% |
| 2002 | 251.03 Million CHF | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 3.47 Billion CHF | 2.45% |
| 2023 Q2 | 3.42 Billion CHF | 1.53% |
| 2023 Q4 | 3.39 Billion CHF | -0.87% |
| 2023 FY | 3.39 Billion CHF | 0.65% |
| 2022 Q4 | 3.37 Billion CHF | 5.86% |
| 2022 Q2 | 3.18 Billion CHF | 7.37% |
| 2022 FY | 3.37 Billion CHF | 13.66% |
| 2021 Q2 | 2.81 Billion CHF | 10.55% |
| 2021 FY | 2.96 Billion CHF | 16.46% |
| 2021 Q4 | 2.96 Billion CHF | 5.35% |
| 2020 Q2 | 2.18 Billion CHF | -8.63% |
| 2020 Q4 | 2.54 Billion CHF | 16.71% |
| 2020 FY | 2.54 Billion CHF | 6.64% |
| 2019 Q2 | 2.22 Billion CHF | 19.44% |
| 2019 Q4 | 2.38 Billion CHF | 7.31% |
| 2019 FY | 2.38 Billion CHF | 28.18% |
| 2018 Q2 | 1.71 Billion CHF | 2.12% |
| 2018 Q4 | 1.86 Billion CHF | 8.79% |
| 2018 FY | 1.86 Billion CHF | 11.09% |
| 2017 Q2 | 1.18 Billion CHF | 8.76% |
| 2017 Q4 | 1.67 Billion CHF | 41.59% |
| 2017 FY | 1.67 Billion CHF | 53.99% |
| 2016 Q4 | 1.08 Billion CHF | -8.11% |
| 2016 Q2 | 1.18 Billion CHF | 13.36% |
| 2016 FY | 1.08 Billion CHF | 4.17% |
| 2015 FY | 1.04 Billion CHF | -9.86% |
| 2015 Q4 | 1.04 Billion CHF | 1.29% |
| 2015 Q2 | 1.03 Billion CHF | -11.01% |
| 2014 Q4 | 1.16 Billion CHF | 10.3% |
| 2014 FY | 1.16 Billion CHF | 13.83% |
| 2014 Q2 | 1.05 Billion CHF | 3.2% |
| 2013 Q4 | 1.01 Billion CHF | 6.36% |
| 2013 Q2 | 958.77 Million CHF | 24.1% |
| 2013 FY | 1.01 Billion CHF | 31.99% |
| 2012 Q2 | 814.67 Million CHF | 0.42% |
| 2012 FY | 772.6 Million CHF | -4.77% |
| 2012 Q4 | 772.6 Million CHF | -5.16% |
| 2011 Q2 | 789.54 Million CHF | -7.54% |
| 2011 FY | 811.26 Million CHF | -4.99% |
| 2011 Q4 | 811.26 Million CHF | 2.75% |
| 2010 FY | 853.89 Million CHF | 6.35% |
| 2010 Q4 | 853.89 Million CHF | 3.3% |
| 2010 Q2 | 826.59 Million CHF | 2.95% |
| 2009 Q4 | 802.94 Million CHF | 0.0% |
| 2009 FY | 802.94 Million CHF | 10.26% |
| 2008 FY | 728.24 Million CHF | -23.06% |
| 2007 FY | 946.48 Million CHF | 46.3% |
| 2006 FY | 646.94 Million CHF | 20.64% |
| 2005 FY | 536.28 Million CHF | 32.57% |
| 2004 FY | 404.53 Million CHF | 14.99% |
| 2003 FY | 351.78 Million CHF | 40.13% |
| 2002 FY | 251.03 Million CHF | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.83 Million USD | -184622.153% |
| Ansell Limited | 3.23 Billion USD | -4.906% |
| Ansell Limited | 3.24 Billion USD | -4.709% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 488.98 Million USD | -594.352% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 300.36 Thousand USD | -1130303.979% |
| Psykey, Inc. | 1.72 Million USD | -196460.3% |
| ConvaTec Group Plc | 3.7 Billion USD | 8.444% |
| ConvaTec Group Plc | 3.71 Billion USD | 8.574% |
| Encision Inc. | 3.81 Million USD | -88998.847% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 651.88 Thousand USD | -520747.21% |
| LifePoint, Inc. | 8.8 Million USD | -38442.832% |
| Medite Cancer Diagnostics, Inc. | 15.95 Million USD | -21179.168% |
| Paradigm Medical Industries, Inc. | 895 Thousand USD | -379263.575% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 5.48 Million USD | -61756.028% |
| Reflect Scientific, Inc. | 2.66 Million USD | -127117.212% |
| SmileDirectClub, Inc. | 597.06 Million USD | -468.668% |
| Sector 10, Inc. | 1000.00 USD | -339530300.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 4.74 Billion USD | 28.463% |
| SheerVision, Inc. | 837.56 Thousand USD | -405277.971% |
| United Health Products, Inc. | 284.64 Thousand USD | -1192728.912% |
| Vasamed, Inc. | 1.6 Million USD | -212074.276% |
| Wearable Health Solutions, Inc. | 223.17 Thousand USD | -1521277.586% |
| Yubo International Biotech Limited | 2.34 Million USD | -144470.163% |